Image

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Join our study on liver health treatments for adults with metabolic issues.

Recruiting
18 years and older
All
Phase 3

The SYNERGY-OUTCOMES study is checking if **retatrutide** and **tirzepatide** can help people with a liver condition called MASLD, which stands for Metabolic Dysfunction-Associated Steatotic Liver Disease. MASLD can lead to serious liver problems. The study will test these medicines against a placebo, which is a harmless pill that doesn't do anything, to see if they work.

About 4,500 adults will join and the study will last around 4 years (or 224 weeks). Participants will visit the clinic 25 to 30 times during the study to check their health and liver function. After the main study, there is an optional 2-year extension where everyone gets the real medicine.

Key Points:

  • The study lasts about 224 weeks with 25 to 30 clinic visits.
  • An optional 2-year extension study offers real treatment to all.
  • This study involves monitoring liver health closely.
Study details
    Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07165028

Eli Lilly and Company

12 September 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.